2023 annual financial data
Elicio Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -35,745,000 USD and net income was -35,195,000 USD.
Operating cash flow was -32,694,000 USD.
Get free Elicio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -35,745,000 USD
- Net income
- -35,195,000 USD
- Operating cash flow
- -32,694,000 USD